Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Apr 22, 2023
Date Accepted: Mar 15, 2024

The final, peer-reviewed published version of this preprint can be found here:

Remote Symptom Monitoring Using Patient-Reported Outcomes in Patients With Chronic Kidney Disease: Process Evaluation of a Randomized Controlled Trial

Grove BE, de Thurah A, Ivarsen P, Kvisgaard AK, Hjollund NH, Grytnes R, Schougaard LMV

Remote Symptom Monitoring Using Patient-Reported Outcomes in Patients With Chronic Kidney Disease: Process Evaluation of a Randomized Controlled Trial

JMIR Form Res 2024;8:e48173

DOI: 10.2196/48173

PMID: 38656781

PMCID: 11079764

Remote Symptom Monitoring Using Patient-Reported Outcomes in Patients With Chronic Kidney Disease: A Process Evaluation of a Randomized Controlled Trial

  • Birgith Engelst Grove; 
  • Annette de Thurah; 
  • Per Ivarsen; 
  • Ann Katrine Kvisgaard; 
  • Niels Henrik Hjollund; 
  • Regine Grytnes; 
  • Liv Marit Valen Schougaard

ABSTRACT

Background:

In Denmark, outpatient follow-up in patients with chronic kidney disease is changing from in-hospital visits toward more remote health care delivery. We developed and implemented an intervention using patient-reported outcome (PRO) measures to monitor the outpatients remotely.

Objective:

This study aimed to provide insight into the intervention process by evaluating (1) the representativity of the study population, (2) patient and physician utilization patterns, (3) patient adherence to the intervention and (4) clinical engagement.

Methods:

A process evaluation determining the reach, dose, fidelity and clinical engagement was carried out alongside a multicenter randomized controlled trial. Data was collected for the PRO intervention arms in the trial from 4 sources: (1) PRO-data from the participants to determine personal factors, (2) the web-based PRO-system to identify key usage intervention patterns, (3) medical records to identify clinical factors relating to the use of the intervention, and (4) semi-structured interviews conducted with a subset of involved physicians.

Results:

Among the 320 invited patients, 152 (48%) accepted to participate. The study population reflected the target population. The adherence rate to the PRO intervention arms was 82%, 95% CI (76;87). The response rate of the questionnaires was 539/544 (99.1%) and the mean item response rate was 14,314/14,788 (96.7%). Physicians assessed 424/539 (79%) of the questionnaires. Physicians found PRO-based remote follow-up beneficial for assessing the patient's health. However, some barriers were emphasized, such as loss of personal relation to the patient and the risk of missing important symptoms in the absence of a face-to-face assessment.

Conclusions:

Overall, utilization of the system showed high usage of the components; reach, dose and fidelity. Qualitative findings suggested a combination of remote and face-to-face consultations as the best approach to manage outpatients. The findings provide guidance on how the intervention may be improved and targeted to the most suitable patients. Clinical Trial: ClinicalTrials.gov Identifier: NCT03847766


 Citation

Please cite as:

Grove BE, de Thurah A, Ivarsen P, Kvisgaard AK, Hjollund NH, Grytnes R, Schougaard LMV

Remote Symptom Monitoring Using Patient-Reported Outcomes in Patients With Chronic Kidney Disease: Process Evaluation of a Randomized Controlled Trial

JMIR Form Res 2024;8:e48173

DOI: 10.2196/48173

PMID: 38656781

PMCID: 11079764

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.